Application Software in Dosage Adjustment for Advanced Cancer Patients With Pain

Chinese Academy of Medical Sciences & Peking Union Medical College

Status and phase: Unknown; Phase 2; Phase 1

Conditions: Oxycodone; Pain; Physicians

Treatments: Device: APP software

Study type: Interventional

Funder types: Other

Identifiers

NCT03016364

CFH2016-3-4025

Details and patient eligibility

About

The purpose of this trial is to determine whether Application (APP) would help clinical doctors to adjust the dose of Oxycodone Hydrochloride Prolonged-release Tablets in advanced patients with cancer pain.

Enrollment: 200 estimated patients

Sex: All

Ages: 18 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• a histologically confirmed diagnosis of Cancer or Sarcoma
• advanced patients with severe cancer pain(score >3)
• having used or expected to use the Oxycodone Hydrochloride Prolonged-release Tablets

Exclusion criteria

• allergic to Oxycodone Hydrochloride Prolonged-release Tablets, or other reasons (determined by clinical doctors) unable to use the Opioids

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

200 participants in 1 patient group

APP in dosage adjustment

Experimental group

Description:

Through the guidance of APP software, clinical doctors try to adjust the dose of Oxycodone Hydrochloride Prolonged-release Tablets for advanced patient's with cancer pain.

Treatment:

Device: APP software